BUZZ-Australia's EBR Systems rises on first patient enrolment in CRT study
I'm PortAI, I can summarize articles.
Shares of EBR Systems (EBR.AX) advance as much as 5.52% to A$0.955, their highest point since December 4 The medtech co reports first patient enrolment and implant in a totally leadless cardiac resynchronization therapy (CRT) study, which could “meaningfully expand” its addressable marketAdds that the study marks a key milestone as it tests WiSE for a potential first-line heart failure therapyStock down 9.3% YTD, including the day’s moves
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments